Results 171 to 180 of about 264,257 (370)

S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8. [PDF]

, 2019
Germinal centres are important sites for antibody diversification and affinity maturation, and are also a common origin of B cell malignancies. Despite being made up of motile cells, germinal centres are tightly confined within B cell follicles. The cues
Cyster, Jason G, Lu, Erick, Muppidi, Jagan R, Wolfreys, Finn D, Xu, Ying   +4 more
core   +1 more source

Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma [PDF]

, 2018
Nicolas Aide, Charline Lasnon, Gandhi Damaj   +2 more
openalex   +1 more source

Tumor Habitats Based on Multiparametric MRI Distinguish Atypical Glioblastoma From Primary Central Nervous System Lymphoma: Imaging‐Pathologic Correlation

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Atypical glioblastoma (GBM) (minimal or no necrosis on MRI) and primary central nervous system lymphoma (PCNSL) are difficult to distinguish on MRI; whether tumor habitat can more accurately distinguish atypical GBM from PCNSL remains uncertain.
Meng‐nan Sun, Hui Wang, Yan‐ying Yang, Xiao‐jun Yu, Hai‐nan Li, Dan‐dan Fu, Dong‐Zhang, Ru‐yu Ai, Xiao‐yu Hua, Li‐chao Wang, Ming‐yao Lai, Chang‐zheng Shi, Lin‐bo Cai   +12 more
wiley   +1 more source

Frontiers in the Management of Orthopaedic Periprosthetic Joint Infection

Journal of Orthopaedic Research, EarlyView.
ABSTRACT Periprosthetic joint infection (PJI) is a devastating complication of total joint arthroplasty (TJA), one of the most frequently performed surgical procedures worldwide. Management of acute PJI commonly involves debridement, antibiotics, and implant retention (DAIR), though failure rates remain high due to antibiotic‐tolerant biofilms. Chronic
Michael F. Shannon, Victoria R. Wong, Samuelson E. Osifo, Timothy Edwards, Himanshu Rao, Jewelia Rempuszewski, Andrew J. Frear, Shaan Sadhwani, Neel B. Shah, Kenneth L. Urish   +9 more
wiley   +1 more source

Primary diffuse large B-cell lymphoma of the CNS, with a Lymphomatosis cerebri pattern [PDF]

, 2021
Balamurugan Thirunavukkarasu, Kirti Gupta, Ritu Shree, Anuj Prabhakar, Aastha Takkar Kapila, Vivek Lal, Bishan Dass Radotra   +6 more
openalex   +1 more source

Recurrent intussusception associated with pneumatosis cystoides coli: A pediatric case report

JPGN Reports, EarlyView.
Abstract Pneumatosis cystoides coli (PCC) describes gas‐filled cysts within the wall of the gastrointestinal tract and is uncommon in children. We report a 7‐year‐old female with a history of recurrent ileocolic intussusception secondary to PCC. Her initial episodes of intussusception resolved spontaneously or with air enema, but no lead point was ...
Sarah Barrett, Tanyaporn Kaenkumchorn, Pooja Thakrar, Rosellen Choi, Rose Lee   +4 more
wiley   +1 more source

Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas [PDF]

, 2007
Integrative genomic and gene-expression analyses have identified amplified oncogenes in B-cell non-Hodgkin lymphoma (B-NHL), but the capability of such technologies to localize tumor suppressor genes within homozygous deletions remains unexplored.
Agirre-Ena, X. (Xabier), Beltran, E. (E.), Climent, J. (J.), Dyer, M.J.S. (Martin J. S.), Fresquet, V. (Vicente), Garcia, J.F. (José Francisco), Karran, E.L. (E. L.), Marin, M. (Miguel), Martinez-Climent, J.A. (José Ángel), Marugan, I. (Isabel), Mestre-Escorihuela, C. (Cinta), Pinkel, D. (Daniel), Prosper, F. (Felipe), Richter, J.A. (José Ángel), Rosenwald, A. (Andreas), Rubio-Moscardo, F. (Fanny), Sanchez, L. (Lydia), Siebert, R. (Reiner), Staudt, L.M. (Louis M.), Sugimoto, K.J. (Kei-Ji), Wheat, L.M. (Luise M.)   +20 more
core  

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo, Antonio Torrelo, Eric L. Simpson, Marjolein De Bruin‐Weller, Diamant Thaçi, Norito Katoh, Silvia Sabatino, Andrew Buchanan, Kasia Morawska, Samuel Ogwu, Karen Denning, Jonathan I. Silverberg   +11 more
wiley   +1 more source

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

New England Journal of Medicine, 2002
B. Coiffier, É. Lepage, J. Brière, R. Herbrecht, H. Tilly, R. Bouabdallah, P. Morel, E. Van Den Neste, G. Salles, P. Gaulard, F. Reyes, P. Lederlin, C. Gisselbrecht   +12 more
semanticscholar   +2 more sources

Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino, Cataldo Patruno, Francesca di Vico, Maddalena Napolitano   +3 more
wiley   +1 more source